Skip to main content

UBS Group AG

Position in WVE — Wave Life Sciences, Inc.

CIK 1610520 ZURICH, V8

Position in WVE

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,935,426
-$972,301 QoQ
Shares Held
505,237
-6.3% QoQ
Ownership
0.256%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 238 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in WVE Over Time

Shares Held

Position Value (USD)

Derivatives in WVE

reported options exposure · as of Jun 30, 2026
CallValue
$531,034
CallShares
91,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. WVE ranks #184 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in WVE

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,935,426 505,237
2026-06-30 $531,034 91,400
2026-03-31 $3,907,727 538,997
2025-12-31 $510,000 30,000
2025-12-31 $4,568,291 268,723
2025-09-30 $5,165,050 705,608
2025-06-30 $3,947,268 607,272
2025-03-31 $1,359,775 168,289
2024-12-31 $1,510,562 122,115
2024-09-30 $564,176 68,802
2024-06-30 $598,365 119,913
2024-03-31 $507,920 82,321
2023-12-31 $411,998 81,584
2023-09-30 $143,077 24,883
2023-06-30 $64,361 17,682
2023-03-31 $7,261 1,677
2022-12-31 $24,437 3,491
2022-09-30 $19,851 5,499
2022-06-30 $10,491 3,228
2022-03-31 $11,116 5,558
2021-12-31 $72,788 23,181
2021-09-30 $23,392 4,774
2021-06-30 $39,966 6,001
2021-03-31 $27,180 4,845
2020-12-31 $51,949 6,601
2020-09-30 $72,097 8,492
2020-06-30 $65,541 6,296
2020-03-31 $47,571 5,077